Intellia Therapeutics, Inc. ($NTLA)
Filing Information
| Accession Number | 0001193125-26-088241 |
|---|---|
| Form Type | 4 |
| Filing Date | Mar 3, 2026 |
| Document | View SEC Filing |
Transactions
3
Total Shares
18,465
Total Value
$8,364.46
P&L
+inf% (+$234,118.38)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
EVP, Chief Technical Officer | Common Stock | โ | Mar 1, 2026 | Grant/Award | 7,353 | $0.00 | $0.00 | 94,471 | Direct | โ | View Details | |
EVP, Chief Technical Officer | Common Stock | โ | Mar 2, 2026 | Sale | 607 | $13.78 | $8,364.46 | 93,864 | Direct | โ | View Details | |
EVP, Chief Technical Officer | Stock Option (right to buy) | Derivative | Mar 1, 2026 | Grant/Award | 10,505 | $0.00 | $0.00 | 10,505 | Direct | โ | View Details |